Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Study 1B: Ciclosporin in the management of steroid resistant Type 1 Reactions in Leprosy
Objective: A pilot study assessing the efficacy and safety of Ciclosporin as a second -line
drug in patients with Type 1 Reactions who have not responded to a 12 week course of
Prednisolone.
Phase:
Phase 2
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Alert Hospital, Ethiopia Armauer Hansen Research Institute, Ethiopia Homes and Hospitals of St Giles